Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commercialization in all fields of use Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Sanofi S.A. […]

thaipr.net

22 เม.ย. 65
1 2,081 2,082 2,083 2,084 2,085 3,076